Cognition Therapeutics (CGTX) Operating Expenses (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Operating Expenses of $8.8 million for Q1 2026, down 35.99% year-over-year from $13.8 million in Q1 2025, and up 2779.94% quarter-over-quarter from -$329000.0 in Q4 2025.
Cognition Therapeutics (CGTX) Operating Expenses (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Operating Expenses for 7 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 35.99% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $28.8 million (up 3831.05% YoY), while the FY2025 annual figure was -$906000.0, down 103.14% from the prior year.
- Operating Expenses advanced to $8.8 million in Q1 2026 per CGTX's latest filing, from -$329000.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $15.2 million in Q4 2023 and bottomed at -$43.7 million in Q4 2024.
- Historically, Operating Expenses has averaged $7.7 million across 5 years, with a median of $12.6 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 141.72% — and 2024, when it tumbled 387.64%.
- Cognition Therapeutics' Operating Expenses stood at $12.6 million in 2022, then grew by 20.31% to $15.2 million in 2023, then sank by 387.64% to -$43.7 million in 2024, then surged by 99.25% to -$329000.0 in 2025, then surged by 2779.94% to $8.8 million in 2026.
- Business Quant data shows CGTX's Operating Expenses at $8.8 million in Q1 2026, -$329000.0 in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | 7.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.74 Mn |
| Mar 31, 2026 | 8.82 Mn |
| Dec 31, 2025 | -329,000.00 |
| Sep 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | 13.98 Mn |
| Mar 31, 2025 | 13.78 Mn |
| Dec 31, 2024 | -43.69 Mn |
| Sep 30, 2024 | 14.46 Mn |
| Jun 30, 2024 | 14.68 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Dec 31, 2023 | 15.19 Mn |
| Sep 30, 2023 | 14.75 Mn |
| Jun 30, 2023 | 11.82 Mn |
| Mar 31, 2023 | 8.97 Mn |
| Sep 30, 2022 | 12.63 Mn |
| Mar 31, 2022 | 9.41 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Sep 30, 2020 | 4.46 Mn |